Abridge is the ambient-AI leader in healthcare — turning clinician-patient conversations into clinical notes, and now a broader “clinician intelligence platform.” Its LinkedIn advertising is one of the most distinctive programs in health tech: it sells trust through science. Alongside brand and founder-led storytelling and marquee PR (a WSJ exclusive on an NVIDIA partnership, a Kaiser Permanente co-development, Becker's features), the backbone is an “evaluations” thought-leadership franchise — employees and executives publishing on how Abridge rigorously evaluates its own AI — positioning evaluation as the moat and the answer to every health system's question: “How do we know we can trust this?”
How Abridge advertises: Abridge's core insight, stated in its own ads: “Evals are the operating system for every single AI company” (CEO Shiv Rao) and “The hard problem is the whole moat” (CTO San Oo). So the program is built to prove trustworthiness. A franchise of thought-leadership ads — run under named employees and executives (Head of Strategic Research Alexandra Chouldechova, ML Science Lead Catherine Chen, plus sales and CS leaders) and “Promoted by Abridge” — publishes “The Science of AI Evaluation for Enterprise Healthcare”: how Abridge measures accuracy, clinical validation, and whether its products are trustworthy. It answers the buyer's real question head-on: “How do we know we can trust this? Every health system asks us the same thing.” On top sits marquee PR used as proof — a Wall Street Journal exclusive (“Nvidia Is Developing an AI Healthcare Model With Startup Abridge”), a Becker's feature on the Abridge–Kaiser Permanente co-development of Care Signals, and a Becker's panel of six health systems on “what it takes to be a lasting AI partner.” Brand and founder storytelling frames the mission (“Healthcare is human and the most human signal is a conversation”), and a founder-led moment — the first-ever Abridge Keynote, where CEO Shiv Rao announces a “patient-centered clinician intelligence platform” — anchors the calendar. The whole thing is unusually intellectual for a B2B program: it recruits its own scientists and leaders as the voice, and makes rigor the product.
Abridge sells trust through science: an “evaluations” thought-leadership franchise under named employees, marquee PR as proof (WSJ/NVIDIA, Kaiser), and founder-led brand and keynote storytelling.
| Format | What Abridge uses it for |
|---|---|
| Thought leadership | Employee/exec “evals science” articles under named people |
| Single image | PR proof (WSJ, Becker's) and evaluation creatives |
| Video | Brand, founder/CTO, and keynote videos |
| Event | The first-ever Abridge Keynote |
Live Abridge creatives with their full ad copy (verbatim), format, theme and CTA.
"The Science of AI Evaluation for Enterprise Healthcare. Shown with Abridge's actual evaluation dashboard (Enterprise Portal) — measuring ambient documentation on attribution, completeness, and fairness across patient groups, checked by LLM judges and production signals. Rigor made visible."
"By Zach Anderson (Abridge): “Every health system asks us the same thing, just in different words.” A General Review of AI Evaluation at Abridge — “it is our responsibility to build AI systems that are trustworthy. We assess this through rigorous evaluations that we conduct across the product lifecycle.” Answering the buyer's core objection directly."
"By Aamir Siddiqi (Abridge): “When you're an AI-native company, one thing that's built into your DNA is ‘evaluation.’” The Science of AI Evaluation for Enterprise Healthcare — are the systems behaving as expected? Are the products having a positive impact? Is a new update ready to launch? Are the products trustworthy?"
"By Alexandra Chouldechova, Head of Strategic Research at Abridge: “This week, I had the privilege of sharing some of the evaluations we…” Linking to “Customer Facing Evaluations: AI Evaluation at Abridge.” Abridge puts its own research scientists forward as the credible voice on evaluation."
"The Wall Street Journal Exclusive: NVIDIA + Abridge on the first clinical conversation foundation model. “The chip giant is joining with the maker of AI note-taking technology to train a model tailored for clinical conversations.” A marquee press win used verbatim as the creative."
"Becker's Healthcare: Abridge and Kaiser Permanente Co-Develop Care Signals to Close Risk Gaps. A named-health-system co-development — powerful proof that a top system builds with Abridge, not just buys from it."
"Becker's Healthcare: Leaders from six health systems weigh in — Partnership Experience / Proven Impact / Pace of Innovation. Positioning Abridge as a durable partner, validated by multiple named systems rather than a single testimonial."
"“That moment between the clinician and patient is where we can build…” A brand video framing Abridge's mission around the clinician-patient conversation — the human signal its ambient AI captures."
"“In the world of AI, you don't want to solve the easy problem. You want to solve the hard problem.” — San Oo, CTO, Abridge. A founder/executive video arguing that solving the hardest problems in clinical AI is the durable competitive advantage."
"Watch: Abridge CEO and Co-Founder Shiv (Shivdev) Rao announces our patient-centered clinician intelligence platform—a single, horizontal intelligence layer connecting providers, payers, and life sciences. Shot from the Abridge Keynote stage, June 11, New York City."
"June 11. 12PM EDT. The first-ever Abridge Keynote. A moody, cinematic teaser building anticipation for a founder-led tentpole event — treating a startup keynote like a product launch moment."
Ad copy and creatives shown verbatim for commentary and analysis; they belong to Abridge (quotes attributed to Shiv Rao, San Oo, Alexandra Chouldechova, Zach Anderson and Aamir Siddiqi of Abridge; PR from The Wall Street Journal, Becker's Healthcare, NVIDIA and Kaiser Permanente). Many creatives run as posts under individual Abridge employees' names, all “Promoted by Abridge” and paid for by Abridge AI Inc. Captured from the public LinkedIn Ad Library.
Every health system asks Abridge “how do we know we can trust this?” — so Abridge built its whole thought-leadership program around answering it with evaluation science. Meeting the core objection head-on, repeatedly and rigorously, is more persuasive than avoiding it.
“Evals are the operating system,” “the hard problem is the whole moat.” Abridge advertises its evaluation methodology — dashboards, measures, LLM judges — as the differentiator. For AI sold into high-stakes settings, showing how you prove trustworthiness can matter more than the feature itself.
Ads run under named researchers, ML leads, and executives (Chouldechova, Chen, Rao, San Oo), “Promoted by Abridge.” Real, credentialed people publishing real thinking reads as substance, not marketing — and multiplies reach through their networks.
A WSJ exclusive on the NVIDIA partnership and Becker's features on Kaiser Permanente become the ad itself. Third-party validation from names buyers already trust (WSJ, NVIDIA, Kaiser) de-risks a young company faster than any self-claim.
“The first-ever Abridge Keynote,” with a cinematic teaser and a CEO platform announcement, treats a startup event like a product launch. A founder-led moment concentrates attention and gives the whole program a story to build toward.
We build LinkedIn and paid programs for high-consideration B2B and healthcare buyers — measured on pipeline, not impressions.
Book a free ad auditBy selling trust through science. Its backbone is an “evaluations” thought-leadership franchise — named employees and executives (CEO Shiv Rao, CTO San Oo, Head of Strategic Research Alexandra Chouldechova, and others) publishing “The Science of AI Evaluation for Enterprise Healthcare” and answering “How do we know we can trust this?” On top sit marquee PR wins used as creative (a WSJ exclusive on an NVIDIA partnership, Becker's features on a Kaiser Permanente co-development and on lasting AI partnership), brand and founder/CTO videos, and a founder-led tentpole — the first-ever Abridge Keynote.
That Abridge is the trustworthy, AI-native leader in clinical AI — turning the human conversation into documentation and intelligence — and that its rigorous evaluation of its own AI (“evals are the operating system”) is what earns the trust of health systems and makes it a lasting partner.
Because trust is the gating factor for AI in healthcare. Health systems' first question is always “how do we know we can trust this?” By making evaluation — how it measures accuracy, safety, and impact — the centerpiece of its advertising, Abridge turns its biggest obstacle into its differentiator and moat.
Turn your buyer's biggest objection into your campaign; make your rigor (how you prove it works) the product, not just the feature; put credentialed employees and scientists forward as the voice; use marquee third-party PR as creative verbatim to de-risk a young brand; and give even a startup a founder-led tentpole event to build the program around.